A股異動 | 三聚環保(300072.SZ)接近漲停 擬對40萬噸/年生物燃料項目追加投資逾6億元
格隆匯7月13日丨三聚環保(300072.SZ)現報5.87元,漲幅9.31%,最新總市值138億。公司10日公告稱,擬以控股子公司山東三聚原有資產為基礎,依託公司擁有的MCT懸浮牀專有技術,對山東三聚原有裝置進行適應性改造,以形成40萬噸/年生物燃料的生產能力。山東三聚計劃以自有資金或自籌資金追加項目投資6.34億元。追加投資項目完成後,該40萬噸/年生物能源項目預計生產生物柴油約40萬噸/年,尾油2.4萬噸/年。每年可實現營業收入約32.08億元,利潤總額約5.71億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.